Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Whole‐genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm
Armando N. Bastidas Torres, Davy Cats, Hailiang Mei, et al.
Genes Chromosomes and Cancer (2019) Vol. 59, Iss. 5, pp. 295-308
Open Access | Times Cited: 18

Showing 18 citing articles:

Sex-BiasedZRSR2Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis
Katsuhiro Togami, Sun Sook Chung, Vikas Madan, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 522-541
Open Access | Times Cited: 46
Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis
Florian Renosi, Anne Roggy, Ambre Giguelay, et al.
Blood Advances (2021) Vol. 5, Iss. 5, pp. 1540-1551
Open Access | Times Cited: 45
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
Jan‐Niklas Eckardt, Friedrich Stölzel, Désirée Kunadt, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD
Naveen Pemmaraju, Nathaniel R. Wilson, Guillermo Garcia‐Manero, et al.
Blood Advances (2022) Vol. 6, Iss. 10, pp. 3027-3035
Open Access | Times Cited: 30
Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm
C. Cameron Yin, Naveen Pemmaraju, M. James You, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5888-5888
Open Access | Times Cited: 29
Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features
Axel Künstner, Julian Schwarting, Hanno M. Witte, et al.
Leukemia (2024) Vol. 38, Iss. 5, pp. 1086-1098
Open Access | Times Cited: 4
Comprehensive clinico‐genetic analysis reveals prognostic factors of blastic plasmacytoid dendritic cell neoplasm
Ji Hyun Lee, Sung Yong Oh, Taek Gyu Lee, et al.
British Journal of Haematology (2025)
Closed Access
A novel MYB::PAIP1 oncogenic fusion in pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is dependent on BCL2 expression and is sensitive to venetoclax
Hansen J. Kosasih, Gerry Healey, Margs S. Brennan, et al.
HemaSphere (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 3
Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review
Yemin Wang, Xiao Li, Lili Yin, et al.
Medicine (2023) Vol. 102, Iss. 7, pp. e32904-e32904
Open Access | Times Cited: 7
Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View
Cosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7099-7099
Open Access | Times Cited: 2
Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells
Florian Renosi, Mary Callanan, Christine Lefebvre
Cancers (2022) Vol. 14, Iss. 17, pp. 4132-4132
Open Access | Times Cited: 11
Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm
Sophia S. Lee, Deborah McCue, Naveen Pemmaraju
Expert Review of Anticancer Therapy (2020) Vol. 20, Iss. 7, pp. 543-550
Closed Access | Times Cited: 12
Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis
Katsuhiro Togami, Sun Sook Chung, Vikas Madan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 9
Novel IKZF1 rearrangement identified in a patient with blastic plasmacytoid dendritic cell neoplasm decreased haematopoietic stem cell function and promoted plasmacytoid dendritic cell abnormality
Le Yin, Qian Yu, Huifang Zhang, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 6, pp. 2496-2500
Closed Access
IKAROS Family Transcription Factors in Lymphocyte Differentiation and Function
Philippe Kastner, Susan Chan
Advances in experimental medicine and biology (2024), pp. 33-52
Closed Access
Genome-wide DNA methylation-analysis delineates blastic plasmacytoid dendritic cell neoplasm from related entities and identifies distinct molecular features
Axel Künstner, Julian Schwarting, Hanno M. Witte, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm
Axel Künstner, Julian Schwarting, Hanno M. Witte, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Pathomorphological and clinical characteristics of blastic plasmocytoid dendritic cell neoplasm. Case report
A. A. Sherstnev, А. М. Ковригина, T. I. Solovyova, et al.
Terapevticheskii arkhiv (2022) Vol. 94, Iss. 7, pp. 891-896
Open Access
Page 1

Scroll to top